Examkin

Question

Difficulty: MediumGastroenterology and Hepatology

Match each complication of decompensated cirrhosis to its most appropriate initial pharmacological or procedural management.

  • Acute esophageal variceal hemorrhageIntravenous octreotide, prophylactic antibiotics (e.g., ceftriaxone), and urgent endoscopy
  • Hepatorenal syndromeSplanchnic vasoconstrictors (e.g., midodrine, octreotide) and intravenous albumin
  • Spontaneous bacterial peritonitisIntravenous third-generation cephalosporin (e.g., cefotaxime) and intravenous albumin
  • Hepatic encephalopathyNonabsorbable disaccharides (e.g., lactulose) and poorly absorbed antibiotics (e.g., rifaximin)
  • Secondary prophylaxis of esophageal varicesNonselective beta-blocker (e.g., nadolol, propranolol) and serial endoscopic band ligation

Answer

Acute esophageal variceal hemorrhage matches with octreotide, prophylactic antibiotics, and urgent endoscopy. Hepatorenal syndrome matches with splanchnic vasoconstrictors and intravenous albumin. Spontaneous bacterial peritonitis matches with third-generation cephalosporin and intravenous albumin. Hepatic encephalopathy matches with nonabsorbable disaccharides and poorly absorbed antibiotics. Secondary prophylaxis of varices matches with nonselective beta-blockers and serial band ligation.
Each correct pairing links the complication of decompensated cirrhosis to its evidence-based initial management. Acute variceal bleeding requires reduction of portal pressure (octreotide), prevention of infection (ceftriaxone), and mechanical hemostasis (endoscopy). Hepatorenal syndrome is a functional renal failure caused by splanchnic vasodilation; treating it involves reversing the vasodilation (midodrine and octreotide) and expanding intravascular volume (albumin). Spontaneous bacterial peritonitis is an ascitic fluid infection necessitating a third-generation cephalosporin and intravenous albumin to prevent subsequent renal failure. Hepatic encephalopathy is driven by excess systemic ammonia, which is treated by decreasing ammonia production and absorption in the gut (lactulose and rifaximin). Finally, secondary prophylaxis of esophageal varices requires reducing baseline portal inflow with nonselective beta-blockers alongside serial band ligation.

Step-by-Step Solution

1
Analyze each complication of cirrhosis presented in the left column to identify the underlying pathophysiologic driver.
Recognize that each complication requires a targeted approach: acute bleeding control, splanchnic vasoconstriction for renal perfusion, infection control for ascitic fluid, ammonia reduction, or long-term portal pressure reduction.
Accurate pathophysiologic understanding dictates the selection of the correct specific therapy from the available choices.
2
Match acute, life-threatening complications (variceal bleed, spontaneous bacterial peritonitis) with their immediate, multi-modal interventions.
Acute variceal bleed pairs with octreotide, antibiotics, and endoscopy. Spontaneous bacterial peritonitis pairs with cefotaxime and albumin.
These are immediate, high-mortality conditions requiring rapid medical stabilization followed by specific targeted treatments.
3
Match subacute complications or prophylactic strategies with their respective maintenance or corrective therapies.
Hepatorenal syndrome is managed with splanchnic vasoconstrictors and albumin; hepatic encephalopathy with lactulose and rifaximin; secondary prophylaxis with nonselective beta-blockers and band ligation.
These interventions target the specific ongoing physiologic derangements, such as gut flora for ammonia or baseline portal pressures for prophylaxis.

Key Concept

Management of decompensated cirrhosis complications
Rate this question

Topics

Gastroenterology and Hepatology

More questions from this topic